RUNX1 and ischemia: He et al. (He et al. 2022) showed that in cardiomyocytes isolated from ex vivo rat hearts subjected to ischemia/reperfusion injury, inhibition of cathepsin-L resulted in an increased calcium transient amplitude, enhanced SERCA activity and improved NCX activity (similar to the effects observed in the Runx1-deficient mice).